(Q47245885)

12 January 2018

title

ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome (English)

1 reference

12 January 2018

1 reference

7

G Remuzzi

1 reference

12 January 2018

1

P Ruggenenti

1 reference

12 January 2018

author name string

L Mosconi

2

1 reference

12 January 2018

G Vendramin

3

1 reference

12 January 2018

M Moriggi

4

1 reference

12 January 2018

A Remuzzi

5

1 reference

12 January 2018

F Sangalli

6

1 reference

12 January 2018

publication date

1 March 2000

1 reference

12 January 2018

American Journal of Kidney Diseases

published in

1 reference

12 January 2018

volume

35

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

page(s)

381-391

1 reference

12 January 2018

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Idiopathic membranous nephropathy: The natural history of untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Recent developments in the management of membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Pathophysiology of Progressive Nephropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

The effects of enalapril on urinary protein excretion in patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Enalapril Can Treat the Proteinuria of Membranous Glomerulonephritis Without Detriment to Systemic or Renal Hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Low-protein diet prevents glomerular damage in adriamycin-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

A model of glomerular ultrafiltration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Structural basis for reduced glomerular filtration capacity in nephrotic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Macromolecule transport across glomerular capillaries: Application of pore theory

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970190-9

7 January 2021

10.1016/S0272-6386(00)70190-9

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018